Posts tagged Spot Therapeutics
Canopy Rivers Portfolio Company Licensed by Health Canada, Triggering Long-Term Cash Flow Stream

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) congratulates Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) and its portfolio company, Spot Therapeutics Inc. (“Spot”), on receiving a cultivation license from Health Canada for its Fredericton-based production and distribution facility. 

Read More